drugset / Trial / NCT04960124
A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) of a single oral dose of JNJ-42847922 in adult participants with hepatic impairment when compared to healthy participants with normal hepatic function.
Timeline
- Start
- 2021-08-05
- Primary completion
- 2021-11-19
- Completion
- 2021-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Seltorexant | Small molecule | — | Oral |
Indications
No indication recorded.